Roivant Sciences Ltd.
ROIVBiotechnology
$37.52+1.10%As of Oct 29vs prior close
- Market cap
- $27.1B
- P/E (TTM)
- –
- From 52W high
- −10.26%
- EPS (LTM)
- -$0.47
- Revenue (LTM)
- $7.5M
- Net margin
- -3534.96%
- Dividend yield
- 0.00%
Nomior Score
64
Steady ProfileTop 18% of the scored universe
Growth—
Quality41
Value56
Momentum95
Resilience53
Growth
−19.07%revenue a year over 5 fiscal years
YE21 $23.8MLTM $7.5M
Connections
Revenue to profitQ1 YE27
The operating loss was 25381% of revenue, wider by 12251 pts on a year.
Who owns it
1fund